ロード中...

A Phase 1b Study of Vismodegib with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

INTRODUCTION: Components of the hedgehog signaling pathway are upregulated in patients with idiopathic pulmonary fibrosis (IPF). Vismodegib, a small-molecule inhibitor of hedgehog signaling, when used in combination with currently available antifibrotic therapy, may be more efficacious than antifibr...

詳細記述

保存先:
書誌詳細
出版年:Pulm Ther
主要な著者: Prasse, Antje, Ramaswamy, Murali, Mohan, Shaun, Pan, Lin, Kenwright, Andrew, Neighbors, Margaret, Belloni, Paula, LaCamera, Peter P.
フォーマット: Artigo
言語:Inglês
出版事項: Springer Healthcare 2019
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6967289/
https://ncbi.nlm.nih.gov/pubmed/32026407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s41030-019-0096-8
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!